Harnessing Evidence on Adverse drug withdrawal events following Deprescribing through the Pharmacovigilance system (HEAD-P)

Información del proyecto

HEAD-P

Identificador del acuerdo de subvención: 101149577

DOI

10.3030/101149577

Proyecto cerrado

Fecha de la firma de la CE 3 Mayo 2024

Fecha de inicio 14 Octubre 2024

Fecha de finalización 13 Octubre 2026

Financiado con arreglo a

• Marie Skłodowska-Curie Actions (MSCA)

Coste total

Sin datos

Aportación de la UE

€ 215 534,40

Coordinado por

ROYAL COLLEGE OF SURGEONS IN IRELAND
Ireland

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved.

Publicaciones

Conference proceedings (3)

Abstracts of ISPEs 2026, 42nd International Conference, August 29–September 2, 2026, Milan

Publicado en: Pharmacoepidemiology and Drug Safety, Edición 35, 2026, ISSN 1053-8569
Editor: Wiley
DOI: 10.1002/PDS.70409

24th ISoP Annual Meeting “Pharmacovigilance: Back to the Future” 24–27 October 2025 Cairo, Egypt

Publicado en: Drug Safety, Edición 48, 2026, ISSN 0114-5916
Editor: Springer Science and Business Media LLC
DOI: 10.1007/S40264-025-01605-X

25th ISoP Global Meeting “Ecosystems of Trust: Pharmacovigilance for a Healthier World” 22–25 September 2026 San José, Costa Rica

Publicado en: Drug Safety, Edición 49, 2026, ISSN 0114-5916
Editor: Springer Science and Business Media LLC
DOI: 10.1007/S40264-026-01704-3

Peer reviewed articles (3)

EPH108 Exploring the Impact of Patient Characteristics and Reporting Period on Adverse Drug Withdrawal Event Signals in the FAERS Database: A Stratified Disproportionality Analysis Study

Autores: Zakir Khan, Frank Moriarty
Publicado en: Value in Health, Edición 28, 2025, ISSN 1098-3015
Editor: Elsevier BV
DOI: 10.1016/J.JVAL.2025.09.1237

Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing

Autores: Zakir Khan, Frank Moriarty
Publicado en: Clinical Pharmacology & Therapeutics, Edición 120, 2026, ISSN 0009-9236
Editor: Wiley
DOI: 10.1002/CPT.70356

Reporting patterns of adverse drug withdrawal events using individual case safety reports in the FAERS and Eudravigilance databases

Autores: Zakir Khan, Ann Sinéad Doherty, Caroline McCarthy, Kieran Dalton, Katharina Tabea Jungo, Emily Reeve, Frank Moriarty
Publicado en: Exploratory Research in Clinical and Social Pharmacy, Edición 23, 2026, ISSN 2667-2766
Editor: Elsevier BV
DOI: 10.1016/J.RCSOP.2026.100828

Other (5)

Recommendations relating to adverse drug withdrawal events in clinical practice guidelines: a protocol for secondary analysis of a scoping review

Autores: Zakir Khan, Aili Langford, Amy Fallon, Ewurabena OfosuAikins, Shin J Liau, Emily Reeve, Frank Moriarty
Publicado en: OSF Registries, 2026
Editor: Center for Open Science

Evidence on drug withdrawal events after medication discontinuation: protocol for an overview of reviews

Autores: Zakir Khan, Katharina Tabea Jungo, Juliet Beatty, Pádraig Cullen, Anne Spinewine, Emily Reeve, Frank Moriarty
Publicado en: PROSPERO, 2025
Editor: Centre for Reviews and Dissemination, University of York / PROSPERO

Perspectives of stakeholders on the integration of adverse drug withdrawal events reporting in the pharmacovigilance system: a qualitative interview study protocol

Autores: Zakir Khan, Anais Essilini, Ann Sinéad Doherty, Michelle Flood, Barbara Clyne, Frank Moriarty
Publicado en: OSF Registries, 2026
Editor: Center for Open Science

Evidence on drug withdrawal events after medication discontinuation: protocol for an overview of reviews

Autores: Zakir Khan, Katharina Tabea Jungo, Juliet Beatty, Pádraig Cullen, Anne Spinewine, Emily Reeve, Frank Moriarty
Publicado en: OSF Registries, 2025
Editor: Center for Open Science

Reporting patterns and disproportionality analysis of adverse drug withdrawal events using individual case safety reports in US and European databases: a study protocol

Autores: Zakir Khan, Kieran Dalton, Katharina Tabea Jungo, Ann Sinéad Doherty, Emily Reeve, Frank Moriarty
Publicado en: OSF Registries, 2025
Editor: Center for Open Science